Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 1882: Gemcitabine pathway SNPs are associated with its PK parameters in patients with solid tumors

Amit K. Mitra, Amit Khatri, Mark N. Kirstein, Robert A. Kratzke, Jatinder K. Lamba

Cancer Res (2012) 72 (8_Supplement): 1882.

https://doi.org/10.1158/1538-7445.AM2012-1882

Published: 15 April 2012

View articletitled, Abstract 1882: Gemcitabine pathway SNPs are associated with its PK parameters in patients with solid tumors

Journal Articles

Abstract 1149: Clinically relevant interactions between micro-RNAs and genes in malignant mesothelioma characterized by an integrated analysis

Chuong D. Hoang, Andrew Gentles, Yue Xu, Sylvia K. Plevritis, Robert Merritt, Richard Whyte, Joseph Shrager, Robert A. Kratzke

Cancer Res (2011) 71 (8_Supplement): 1149.

https://doi.org/10.1158/1538-7445.AM2011-1149

Published: 15 April 2011

View articletitled, Abstract 1149: Clinically relevant interactions between micro-RNAs and genes in malignant mesothelioma characterized by an integrated analysis

Journal Articles

Repression of Cap-Dependent Translation Attenuates the Transformed Phenotype in Non–Small Cell Lung Cancer Both In vitro and In vivo

Blake A. Jacobson, Michael D. Alter, Marian G. Kratzke, Sandra P. Frizelle, Ying Zhang, Mark S. Peterson, Svetlana Avdulov, Riikka P. Mohorn, Bryan A. Whitson, Peter B. Bitterman, Vitaly A. Polunovsky, Robert A. Kratzke

Cancer Res (2006) 66 (8): 4256–4262.

https://doi.org/10.1158/0008-5472.CAN-05-2879

Published: 17 April 2006

View articletitled, Repression of Cap-Dependent Translation Attenuates the Transformed Phenotype in Non–Small Cell Lung Cancer Both In vitro and In vivo

Journal Articles

Endpoint determination for gemcitabine treatment in the in vitro cell culture bioreactor system

Mark N. Kirstein, Richard C. Brundage, Megan M. Moore, Lisa A. Hillman, Paul H. Marker, Robert A. Kratzke, Doug Yee

Cancer Res (2006) 66 (8_Supplement): 733.

Published: 15 April 2006

View articletitled, Endpoint determination for gemcitabine treatment in the in vitro cell culture bioreactor system

Journal Articles

Mutation of c-Met RTK: A novel molecular therapeutic target for the treatment of mesothelioma

Ramasamy Jagadeeswaran, Patrick C. Ma, Tanguy Y. Seiwert, Sujatha Jagadeeswaran, Osvaldo Zumba, Vidya Nallasura, Salman Ahmed, Robert A. Kratzke, Gavin J. Gordon, David J. Sugarbaker, Raphael Bueno, Varalakshmi Janamanchi, Vytas P. Bindokas, Hedy L. Kindler, Ravi Salgia

Cancer Res (2006) 66 (8_Supplement): 713.

Published: 15 April 2006

View articletitled, Mutation of c-Met RTK: A novel molecular therapeutic target for the treatment of mesothelioma

Journal Articles

Ras pathway activation in mesothelioma

Manish R. Patel, Blake A. Jacobson, Faris Farassati, Robert A. Kratzke

Cancer Res (2006) 66 (8_Supplement): 995.

Published: 15 April 2006

View articletitled, Ras pathway activation in mesothelioma

Journal Articles

Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma

Ramasamy Jagadeeswaran, Patrick C. Ma, Tanguy Y. Seiwert, Sujatha Jagadeeswaran, Osvaldo Zumba, Vidya Nallasura, Salman Ahmed, Rosangela Filiberti, Michela Paganuzzi, Riccardo Puntoni, Robert A. Kratzke, Gavin J. Gordon, David J. Sugarbaker, Raphael Bueno, Varalakshmi Janamanchi, Vytas P. Bindokas, Hedy L. Kindler, Ravi Salgia

Cancer Res (2006) 66 (1): 352–361.

https://doi.org/10.1158/0008-5472.CAN-04-4567

Published: 05 January 2006

View articletitled, Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma

Journal Articles

Activated c-Met receptor tyrosine kinase: A novel molecular therapeutic target for the treatment of malignant pleural mesothelioma

Ramasamy Jagadeeswaran, Patrick C. Ma, Hedy L. Kindler, Sujatha Jagadeeswaran, Tanguy Seiwert, Osvaldo Zumba, Gavin J. Gordon, Robert A. Kratzke, David J. Sugarbaker, Raphael Bueno, Ravi Salgia

Cancer Res (2005) 65 (9_Supplement): 604.

Published: 01 May 2005

View articletitled, Activated c-Met receptor tyrosine kinase: A novel molecular therapeutic target for the treatment of malignant pleural mesothelioma

Journal Articles

Repression of cap-dependent translation by 4E-BP1 inhibits malignancy in non-small cell lung cancer both in vitro and in vivo

Blake A. Jacobson, Sandra P. Frizelle, Marian G. Kratzke, Michael D. Alter, Bryan P. Whitson, Mark Peterson, Peter B. Bitterman, Vitaly A. Polunovsky, Robert A. Kratzke

Cancer Res (2005) 65 (9_Supplement): 439.

Published: 01 May 2005

View articletitled, Repression of cap-dependent translation by 4E-BP1 inhibits malignancy in non-small cell lung cancer both in vitro and in vivo

Journal Articles

Selective Activation of Insulin Receptor Substrate-1 and -2 in Pleural Mesothelioma Cells: Association with Distinct Malignant Phenotypes

Chuong D. Hoang, Xihong Zhang, Paul D. Scott, Tenner J. Guillaume, Michael A. Maddaus, Douglas Yee, Robert A. Kratzke

Cancer Res (2004) 64 (20): 7479–7485.

https://doi.org/10.1158/0008-5472.CAN-04-1898

Published: 15 October 2004

View articletitled, Selective Activation of Insulin Receptor Substrate-1 and -2 in Pleural Mesothelioma Cells: Association with Distinct Malignant Phenotypes

Journal Articles

Expression profiling of paired cells from primary lung tumors and lymph node metastases: Implications for molecular mechanisms of metastasis

Chuong D. Hoang, Tenner J. Guillaume, Sherif H. Tawfic, Robert A. Kratzke, Michael A. Maddaus

Cancer Res (2004) 64 (7_Supplement): 402.

Published: 01 April 2004

View articletitled, Expression profiling of paired cells from primary lung tumors and lymph node metastases: Implications for molecular mechanisms of metastasis

Journal Articles

Derangement of the IGF system in malignant mesothelioma: IGF-1 induces cell proliferation via insulin receptor substrate-1

Chuong D. Hoang, Xihong Zhang, Paul D. Scott, Michael A. Maddaus, Douglas Yee, Robert A. Kratzke

Cancer Res (2004) 64 (7_Supplement): 1197–1198.

Published: 01 April 2004

View articletitled, Derangement of the IGF system in malignant mesothelioma: IGF-1 induces cell proliferation via insulin receptor substrate-1

Journal Articles

Translational repression by 4E-BP1 diminishes transcriptional activation of critical growth regulatory genes in non-small cell lung carcinoma.

Chuong D. Hoang, Blake A. Jacobson, Sandra P. Frizelle, Peter B. Bitterman, Vitaly A. Polunovsky, Robert A. Kratzke

Cancer Res (2004) 64 (7_Supplement): 839.

Published: 01 April 2004

View articletitled, Translational repression by 4E-BP1 diminishes transcriptional activation of critical growth regulatory genes in non-small cell lung carcinoma.

Journal Articles

Human Lung Carcinomas Express Fas Ligand

Gloria A. Niehans, Thomas Brunner, Sandra P. Frizelle, Jacob C. Liston, Christopher T. Salerno, Dennis J. Knapp, Douglas R. Green, Robert A. Kratzke

Cancer Res (1997) 57 (6): 1007–1012.

Published: 01 March 1997

View articletitled, Human Lung Carcinomas Express Fas Ligand

Journal Articles

Rb and p16^INK4a Expression in Resected Non-Small Cell Lung Tumors

Robert A. Kratzke, Todd M. Greatens, Jeffrey B. Rubins, Michael A. Maddaus, Dennis E. Niewoehner, Gloria A. Niehans, Joseph Geradts

Cancer Res (1996) 56 (15): 3415–3420.

Published: 01 August 1996

View articletitled, Rb and p16INK4a Expression in Resected Non-Small Cell Lung Tumors

Journal Articles

Immunohistochemical Detection of the Cyclin-dependent Kinase Inhibitor 2/Multiple Tumor Suppressor Gene 1 (CDKN2/MTS1) Product p16^INK4A in Archival Human Solid Tumors: Correlation with Retinoblastoma Protein Expression

Joseph Geradts, Robert A. Kratzke, Gloria A. Niehans, Clint E. Lincoln

Cancer Res (1995) 55 (24): 6006–6011.

Published: 01 December 1995

View articletitled, Immunohistochemical Detection of the Cyclin-dependent Kinase Inhibitor 2/Multiple Tumor Suppressor Gene 1 (CDKN2/MTS1) Product p16INK4A in Archival Human Solid Tumors: Correlation with Retinoblastoma Protein Expression

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 1882: Gemcitabine pathway SNPs are associated with its PK parameters in patients with solid tumors

Abstract 1149: Clinically relevant interactions between micro-RNAs and genes in malignant mesothelioma characterized by an integrated analysis

Repression of Cap-Dependent Translation Attenuates the Transformed Phenotype in Non–Small Cell Lung Cancer Both In vitro and In vivo

Endpoint determination for gemcitabine treatment in the in vitro cell culture bioreactor system

Mutation of c-Met RTK: A novel molecular therapeutic target for the treatment of mesothelioma

Ras pathway activation in mesothelioma

Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma

Activated c-Met receptor tyrosine kinase: A novel molecular therapeutic target for the treatment of malignant pleural mesothelioma

Repression of cap-dependent translation by 4E-BP1 inhibits malignancy in non-small cell lung cancer both in vitro and in vivo

Selective Activation of Insulin Receptor Substrate-1 and -2 in Pleural Mesothelioma Cells: Association with Distinct Malignant Phenotypes

Expression profiling of paired cells from primary lung tumors and lymph node metastases: Implications for molecular mechanisms of metastasis

Derangement of the IGF system in malignant mesothelioma: IGF-1 induces cell proliferation via insulin receptor substrate-1

Translational repression by 4E-BP1 diminishes transcriptional activation of critical growth regulatory genes in non-small cell lung carcinoma.

Human Lung Carcinomas Express Fas Ligand

Rb and p16^INK4a Expression in Resected Non-Small Cell Lung Tumors

Immunohistochemical Detection of the Cyclin-dependent Kinase Inhibitor 2/Multiple Tumor Suppressor Gene 1 (CDKN2/MTS1) Product p16^INK4A in Archival Human Solid Tumors: Correlation with Retinoblastoma Protein Expression

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only